Wilson Lab at Vanderbilt
Vanderbilt University
Joined April 2015
- Tweets657
- Following1.2K
- Followers1.5K
- Likes3.4K
Immunoengineering Lab retweeted
#PhF26 awardee Dr. Anastasia Varanko, a postdoc @VUEngineering, aims to make existing #immunotherapies more effective to expand their benefit to a broader range of patients & #cancer types. @AVaranko121
Watch the full interview to learn more about Anya: phrmafoundation.org/news-eve…
Immunoengineering Lab retweeted
Immunotherapy often fails b/c tumors “turn off” the immune system. #PhF26 awardee Dr. Anastasia Varanko @WilsonLabVU @VanderbiltU is engineering a targeted therapy that reprograms suppressive immune cells in tumors to instead attack #cancer. @AVaranko121
phrmafoundation.org/grants-f…
Huge congratulations to Dr. Ella Adjei-Sowah (@easa_me) on her @CancerResearch Postdoctoral Fellowship!
The Cancer Research Institute is honored to share the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows. Meet this new class of visionaries, backed by CRI's urgent commitment to keep progress moving forward: bit.ly/3KOsT2J #CancerResearch
Immunoengineering Lab retweeted
The Cancer Research Institute is honored to share the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows. Meet this new class of visionaries, backed by CRI's urgent commitment to keep progress moving forward: bit.ly/3KOsT2J #CancerResearch
Congratulations to @AVaranko121 on being selected for a @PhRMAfoundation Fellowship to support her work on Treg-targeted immunotherapies!
The PhRMA Foundation is pleased to award 50 early-career researchers with a total of more than $3.6 million in 2026 #fellowships and #grants focused on #DrugDiscovery, #DrugDelivery, and #Translational medicine research.
View the #PhF26 awardees: phrmafoundation.org/news-eve…
Immunoengineering Lab retweeted
The PhRMA Foundation is pleased to award 50 early-career researchers with a total of more than $3.6 million in 2026 #fellowships and #grants focused on #DrugDiscovery, #DrugDelivery, and #Translational medicine research.
View the #PhF26 awardees: phrmafoundation.org/news-eve…
This year I am riding with Clip in 4 the Cure to help raise funding to support cancer research. Please visit our team site at: give.vanderbilthealth.org/fu… and consider giving what you can to support the Vanderbilt-Ingram Cancer Center!
Immunoengineering Lab retweeted
Macromolecular Diamidobenzimidazole Conjugates Can Activate Stimulator of Interferon Genes | Journal of the American Chemical Society @VanderbiltU pubs.acs.org/doi/10.1021/jac…
Immunoengineering Lab retweeted
Join us for #IMES2025!
🚨 The abstract deadline is approaching for trainees and early career PI's! Due: Aug. 15, 2025
📢 Travel scholarships are available for students and postdocs from underrepresented or disadvantaged backgrounds!
👉Learn more/submit: tinyurl.com/DIMES2025
Immunoengineering Lab retweeted
Researchers led by @VanderbiltU School of Engineering associate prof. John T. Wilson, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. Read more: ow.ly/VA5250WaQR0
Immunoengineering Lab retweeted
Writing is thinking bit.ly/43IMb02
Congrats to @WilsonLabVU @VanderbiltVinse graduate student Jack Loken on earning an @NSF GRFP award!!
Today, NSF announced an add’l 500 NSF Graduate Research Fellowship Program awardees for the 2025-2026 cohort, bringing the total to approx 1,500. #NSFGRFP supports grad students as they pursue their dreams, build STEM skills, & become the next generation of innovators & leaders.
ALT NSF logo
Immunoengineering Lab retweeted
Engineering a STING Agonist-Powered Immune Response with Nanobody Conjugates - Kimryn Rathmell
@NCIDirector | @BlaiseKimmel | @neil_chada
oncodaily.com/insight/kimryn…
#OncoDaily #Oncology #Cancer #MedX #MedEd #NanobodyConjugates
Excited to share our latest publication in @natBME! Big congrats to all co-authors on this highly collaborative effort – especially to first author @BlaiseKimmel for his dedication to this project! Check out the paper (open access) here:
nature.com/articles/s41551-0…
Immunoengineering Lab retweeted
The Cancer Nanotechnology Gordon Research Conference is just a few months away! Applications for the trainee-focused GRS are due by March 9 to be considered for an oral presentation. Hope to see you in Italy! grc.org/cancer-nanotechnolog…
We are recruiting Postdoctoral Fellows to lead new projects focused on engineering of extracellular vesicles for drug delivery, gene editing, and immunotherapy for cancer and autoimmunity! Learn more about the position at tinyurl.com/366zr4fw!
Check out our @Nature News & Views perspective article an exciting new cancer vaccine technology.
This vaccine technology stimulates a killer T cell response in mouse models of cancer and SARS-CoV-2 infection
go.nature.com/4hSXx5f
Immunoengineering Lab retweeted
Next talking about turning ‘cold’ tumors ‘hot’ with targeted immunotherapy is Dr. Anya Varanko from @WilsonLabVU.
Immunoengineering Lab retweeted
STING agonist-based ER-targeting molecules boost antigen cross-presentation @Nature
nature.com/articles/d41586-0…
nature.com/articles/s41586-0…
